-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GlegMKKWyVuVz8342aBZmXnPUJLr8us3IGPxoRVpi0BCvZidQWQ5Pnt3MRzQrWhB y0gkAiQkwuVPEQ1BEjzyFw== 0001029869-98-000123.txt : 19980211 0001029869-98-000123.hdr.sgml : 19980211 ACCESSION NUMBER: 0001029869-98-000123 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980210 SROS: NONE GROUP MEMBERS: ARTHUR J. MARKS GROUP MEMBERS: C. RICHARD KRAMLICH GROUP MEMBERS: CHARLES W. NEWHALL III GROUP MEMBERS: CORNELIUS C. BOND, JR. GROUP MEMBERS: FRANK A. BONSAL, JR. GROUP MEMBERS: NANCY L. DORMAN GROUP MEMBERS: NEA ONSET PARTNERS, LIMITED PARTNERSHIP GROUP MEMBERS: NEA PARTNERS V, LIMITED PARTNERSHIP GROUP MEMBERS: NEW ENTERPRISE ASSOCIATES V LTD PARTNERSHIP ET AL GROUP MEMBERS: THOMAS C. MCCONNELL SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-45385 FILM NUMBER: 98527884 BUSINESS ADDRESS: STREET 1: 1525 INDUSTRIA WAY CITY: BELMONT STATE: CA ZIP: 94002 BUSINESS PHONE: 4153540700 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NEW ENTERPRISE ASSOCIATES V LTD PARTNERSHIP ET AL CENTRAL INDEX KEY: 0000938809 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1119 ST PAUL ST CITY: BALTIMORE STATE: MD ZIP: 21202 MAIL ADDRESS: STREET 1: 1119 ST PAUL ST CITY: BALTIMORE STATE: MD ZIP: 21202 SC 13G/A 1 INHALE THERAPEUTIC SYSTEMS FORM SCHEDULE 13G/A ------------------------- OMB APPROVAL ------------------------- OMB Number: 3235-0145 Expires: October 31, 1994 Estimated average burden hours per response...14.90 ------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Inhale Therapeutic Systems -------------------------- (Name of Issuer) Common Stock, no par value ------------------------------ (Title of Class of Securities) 457191104 -------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Item 1(a). Name of Issuer: Inhale Therapeutic Systems. Item 1(b). Address of Issuer's Principal Executive Offices: 1525 Industrial Way, Belmont, CA 94002. Item 2(a). Names of Persons Filing: New Enterprise Associates V, Limited Partnership ("NEA V"), NEA Partners V, Limited Partnership ("NEA Partners V"), which is the sole general partner of NEA V, NEA ONSET Partners, Limited Partnership ("ONSET Partners") and Cornelius J. Bond, Jr. ("Bond"), Frank A. Bonsal, Jr. ("Bonsal"), Nancy L. Dorman ("Dorman"), C. Richard Kramlich ("Kramlich"), Arthur J. Marks ("Marks"), Thomas C. McConnell ("McConnell") and Charles W. Newhall III ("Newhall") (collectively, the "General Partners"). Bonsal, Dorman, Kramlich, Marks, McConnell and Newhall are individual general partners of NEA Partners V. Bond, Bonsal, Dorman, Kramlich, Marks, McConnell and Newhall are individual general partners of ONSET Partners. The persons named in this paragraph are referred to individually herein as a "Reporting Person" and collectively as the "Reporting Persons." Item 4. Ownership. Not applicable. Item 5. Ownership of Five Percent or Less of a Class. Each Reporting Person has ceased to be the beneficial owner of more than five percent of outstanding Common Stock of Inhale Therapeutic Systems. All other items of this Schedule 13G remain the same as reported on the Schedule 13G dated as of February 10, 1997 and filed on behalf of the Reporting Persons with respect to the Common Stock of Inhale Therapeutic Systems, except to reflect that each of the Reporting Persons has ceased to be the beneficial owner of more than five percent of the Common Stock of Inhale Therapeutic Systems. Page 2 of 6 Pages SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: February 10, 1998 NEW ENTERPRISE ASSOCIATES V, LIMITED PARTNERSHIP By: NEA PARTNERS V, LIMITED PARTNERSHIP By: * _____________________________________ Charles W. Newhall III General Partner NEA PARTNERS V, LIMITED PARTNERSHIP By: * _____________________________________ Charles W. Newhall III General Partner NEA ONSET Partners, Limited Partnership By: * _____________________________________ Charles W. Newhall III General Partner * ______________________________________ Cornelius C. Bond, Jr. Page 3 of 6 Pages * ______________________________________ Frank A. Bonsal, Jr. * ______________________________________ C. Richard Kramlich * ______________________________________ Arthur J. Marks * ______________________________________ Thomas C. McConnell * ______________________________________ Charles W. Newhall III *By: /s/ Nancy L. Dorman Nancy L. Dorman, in her individual capacity and as Attorney-in-Fact ________________________________________________________________________________ This Schedule 13G was executed by Nancy L. Dorman pursuant to Powers of Attorney filed with the Securities and Exchange Commission on February 13, 1992 in connection with a Schedule 13G for Advanced Interventional Systems Inc. and on February 13, 1995 in connection with a Schedule 13G for Acuity Imaging, Inc., which Powers of Attorney are incorporated herein by reference. Page 4 of 6 Pages Exhibit 1 --------- AGREEMENT Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Inhale Therapeutic Systems. EXECUTED as a sealed instrument this 10th day of February, 1998. NEW ENTERPRISE ASSOCIATES V, LIMITED PARTNERSHIP By: NEA PARTNERS V, LIMITED PARTNERSHIP By: * _____________________________________ Charles W. Newhall III General Partner NEA PARTNERS V, LIMITED PARTNERSHIP By: * _____________________________________ Charles W. Newhall III General Partner NEA ONSET Partners, Limited Partnership By: * _______________________________________ Charles W. Newhall III General Partner * _______________________________________ Cornelius C. Bond, Jr. Page 5 of 6 Pages * _______________________________________ Frank A. Bonsal, Jr. * _______________________________________ C. Richard Kramlich * _______________________________________ Arthur J. Marks * _______________________________________ Thomas C. McConnell * _______________________________________ Charles W. Newhall III *By: /s/ Nancy L. Dorman ___________________________________ Nancy L. Dorman, in her individual capacity and as Attorney-in-Fact ________________________________________________________________________________ This Agreement was executed by Nancy L. Dorman pursuant to Powers of Attorney filed with the Securities and Exchange Commission on February 13, 1992 in connection with a Schedule 13G for Advanced Interventional Systems Inc. and on February 13, 1995 in connection with a Schedule 13G for Acuity Imaging, Inc., which Powers of Attorney are incorporated herein by reference. -----END PRIVACY-ENHANCED MESSAGE-----